Paper8736614
Adverse effects of antipsychotic agents. Do newer agents offer advantages?
Owens DG. Drugs, 1996. Cited by 74 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Adverse effects of antipsychotic agents. Do newer agents offer advantages? Papers, record 8736614. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8736614
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Schizophrenia | Major topic |
| Humans |
Source PubMed
References166
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,035,301 | "Negative symptoms": conceptual and methodological problems. | Schizophr Bull | 1985 | https://conductscience.org/library/papers/4035301 | PubMed |
| 2 | 7,514,366 | Risperidone in the treatment of schizophrenia. | Am J Psychiatry | 1994 | https://conductscience.org/library/papers/7514366 | PubMed |
| 3 | 1,978,477 | Experiences of long-term treatment with remoxipride: efficacy and tolerability. | Acta Psychiatr Scand Suppl | 1990 | https://conductscience.org/library/papers/1978477 | PubMed |
| 4 | 1,924,636 | Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist. | Psychopharmacology (Berl) | 1991 | https://conductscience.org/library/papers/1924636 | PubMed |
| 5 | 3,358,462 | Deficit and nondeficit forms of schizophrenia: the concept. | Am J Psychiatry | 1988 | https://conductscience.org/library/papers/3358462 | PubMed |
| 6 | 5,100,620 | Agranulocytosis, leukopenia, and psychotropic drugs. | Arch Gen Psychiatry | 1971 | https://conductscience.org/library/papers/5100620 | PubMed |
| 7 | 8,515,788 | Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8515788 | PubMed |
| 8 | 1,358,126 | PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. | Br J Psychiatry Suppl | 1992 | https://conductscience.org/library/papers/1358126 | PubMed |
| 9 | 7,527,886 | Risperidone-induced neuroleptic malignant syndrome in young patient. | Lancet | 1994 | https://conductscience.org/library/papers/7527886 | PubMed |
| 10 | 8,301,292 | Acute dystonia due to clozapine. | J Neurol Neurosurg Psychiatry | 1994 | https://conductscience.org/library/papers/8301292 | PubMed |
| 11 | 1,976,107 | The European experience with use of clozapine. | Hosp Community Psychiatry | 1990 | https://conductscience.org/library/papers/1976107 | PubMed |
| 12 | 1,352,050 | A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia. | Psychopharmacology (Berl) | 1992 | https://conductscience.org/library/papers/1352050 | PubMed |
| 13 | 1,903,019 | 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin. | Acta Psychiatr Scand | 1991 | https://conductscience.org/library/papers/1903019 | PubMed |
| 14 | 7,537,287 | Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia. | J Clin Psychopharmacol | 1995 | https://conductscience.org/library/papers/7537287 | PubMed |
| 15 | 7,908,676 | Clozapine treatment after agranulocytosis induced by classic neuroleptics. | J Clin Psychopharmacol | 1994 | https://conductscience.org/library/papers/7908676 | PubMed |
| 16 | 2,568,378 | Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. | Int Clin Psychopharmacol | 1989 | https://conductscience.org/library/papers/2568378 | PubMed |
| 17 | 1,675,900 | The effects of clozapine on tardive dyskinesia. | Br J Psychiatry | 1991 | https://conductscience.org/library/papers/1675900 | PubMed |
| 18 | 7,961,551 | Motor and mental side effects of clozapine. | J Clin Psychiatry | 1994 | https://conductscience.org/library/papers/7961551 | PubMed |
| 19 | 1,978,483 | Neuropharmacological and behavioural properties of remoxipride in the rat. | Acta Psychiatr Scand Suppl | 1990 | https://conductscience.org/library/papers/1978483 | PubMed |
| 20 | 7,520,908 | Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. | J Clin Psychiatry | 1994 | https://conductscience.org/library/papers/7520908 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,720,508 | Clozapine blood level assessment using a point-of-care device: feasibility and reliability. | Ther Adv Psychopharmacol | 2022 | https://conductscience.org/library/papers/35720508 | PubMed |
| 20,865,083 | Antipsychotics and risk of venous thromboembolism: A population-based case-control study. | Clin Epidemiol | 2009 | https://conductscience.org/library/papers/20865083 | PubMed |
| 14,647,964 | Neuroleptic dysphoria: towards a new synthesis. | Psychopharmacology (Berl) | 2004 | https://conductscience.org/library/papers/14647964 | PubMed |
| 12,383,032 | Antipsychotic-induced venous thromboembolism: a review of the evidence. | CNS Drugs | 2002 | https://conductscience.org/library/papers/12383032 | PubMed |
| 11,607,043 | Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist. | CNS Drug Rev | 2001 | https://conductscience.org/library/papers/11607043 | PubMed |
| 10,843,459 | Biotransformation of post-clozapine antipsychotics: pharmacological implications. | Clin Pharmacokinet | 2000 | https://conductscience.org/library/papers/10843459 | PubMed |
| 9,683,987 | Risperidone-induced photosensitivity. | Postgrad Med J | 1998 | https://conductscience.org/library/papers/9683987 | PubMed |
| 9,098,656 | Drug-induced movement disorders. | Drug Saf | 1997 | https://conductscience.org/library/papers/9098656 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8736614
GET https://conductscience.org/api/papers/v1/8736614/references?page=2